Agios Pharmaceuticals (AGIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Red Cat Holdings, Inc. is positioned to benefit from the FCC's Section 1709 ruling, which restricts major foreign drone competitors from the U.S. market. RCAT's NDAA-compliant, American-made drones enable expansion into commercial markets previously dominated by Chinese players like DJI and Autel Robotics. Management guides FY25 revenue to $34.5–$37.5 million, requiring a record Q4, with military contracts—especially the Army Short-Range Reconnaissance program—remaining the key growth driver.

For decades, small-cap value was one of the most potent factor combinations, but that compelling history doesn't mean small-cap value wins out every year. There are times when “junkier” small stocks beat broader small-cap indexes.

Increasing attention is currently paid to a small number of stocks commanding outsized (and record) percentages of widely followed cap-weighted indexes. Meanwhile, advisors and investors are reviewing the equal-weight methodology.

Investors need to pay close attention to Brown & Brown stock based on the movements in the options market lately.

Cybersecurity demand is set to grow through 2026, and QLYS, FTNT, CRWD & PANW are the four stocks with strong demand signals and competitive moats.

AMZN, MSFT and GOOGL are gearing up for a potential 2026 cloud boom as AI-driven demand lifts cloud growth and spurs massive data center investment.

LOS ANGELES, Dec. 26, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 20, 2025 and September 24, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 2, 2026.

Colgate-Palmolive NYSE: CL is a buy-and-hold quality stock offering significant incentives to consumer staples investors. The stock is trading at historically low valuations, pays a higher-than-average yield, can sustain its capital return, will grow its business in 2026, and buys back shares, to name a few.

CMS to invest $20B in grid upgrades and clean power, with plans to add major solar, wind, and battery capacity despite regulatory and debt pressures.

Philadelphia, Pennsylvania--(Newsfile Corp. - December 26, 2025) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit against Six Flags Entertainment Corp. (NYSE: FUN) ("Six Flags" or the "Company") has been filed on behalf of investors who purchased or acquired Six Flags shares during the period of July 1, 2024 through November 5, 2025 (the "Class Period"), including in connection with the merger between Six Flags and Cedar Fair L.P. (the "Merger").

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

ECD announcing a major expansion of its product lineup for 2026. The new programs span heritage-inspired sports coupes, classic SUVs, and modern lifestyle.

SAN DIEGO, Dec. 26, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Klarna Group plc (NYSE: KLAR) securities pursuant and/or traceable to Klarna's offering documents issued in connection with Klarna's September 10, 2025 initial public offering (the “IPO”), have until February 20, 2026 to seek appointment as lead plaintiff of the Klarna class action lawsuit. Captioned Nayak v.

VICI Properties offers a 6.5% yield with a strong, consistent dividend growth history and robust coverage ratios. VICI's intrinsic value is calculated at $31.66, above its current price, suggesting both yield and capital appreciation potential. Dividend growth assumptions are conservative, with management maintaining a prudent payout ratio and ongoing expansion plans.

JNJ's rapidly advancing pipeline, new drug approvals and expanding cancer and neuroscience portfolio could fuel growth through the next decade.

FIX enters 2026 with surging mechanical and electrical revenues, a record backlog and tech-driven demand supporting earnings stability.

BHVN's investment case definitely weakened after Opakalim's Phase 2 MDD miss. This also means they'll discontinue their psychiatric development. BHVN's pipeline remains diverse, but key assets like Opakalim for depression and Taldefgrobep alfa for SMA missed primary endpoints. Current cash runway is approximately 3.1 quarters, heightening urgency for successful near-term clinical milestones and FDA approvals.

NVDA, MU, LRCX and APH are some of the hardware-focused stocks that are positioned to benefit from the growing demand for consumer electronics.

TSLA lands a 1 GWh Megapack deal in Scotland, boosting its energy storage business as UK grids push for Net Zero and clean power goals.